Skip to content
Search

Latest Stories

Submit Guest Post

Indian pharmacist dies after drinking botched coronavirus treatment

An Indian pharmacist died and his boss was left hospitalised after the pair drank a chemical concoction they had developed in an effort to treat coronavirus, police said Saturday.

The men worked for a herbal medicine company and were testing their treatment -- a mix of nitric oxide and sodium nitrate -- at a home in southern Chennai city.


K Sivanesan, 47, died on the spot, said local police chief Ashok Kumar.

His colleague Rajkumar was recovering from the poisoning.

Kumar said Sivanesan bought the chemicals from a local market and developed the formula after conducting research on the internet.

There are no approved medicines or vaccines for treating COVID-19, triggering a global race for a new drug for the disease that has killed nearly 300,000 people.

Nearly 60,000 cases have been detected in India, which has imposed a drastic nationwide lockdown in an effort to halt the spread of the disease.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Free Soul

Rohini and Arjun Sofat turned a gap in women’s wellness into a £42 million business

Company handout

Investors dismissed their idea, but this Asian mother and son built Free Soul into a £42m brand

  • Free Soul recorded £42 million in sales in the year to April 2026.
  • The mother-and-son founders struggled to convince investors that women’s wellness was a viable market.
  • The business is now targeting £100 million in sales by 2028.

When Rohini Sofat went looking for supplements to support her energy and wellbeing, she found plenty of products aimed at men and plenty of women's products focused on weight loss and appearance. What she could not find was something designed around how women actually felt.

That gap eventually became the foundation for Free Soul, the London-based women’s wellness and nutrition business she built with her son, Arjun Sofat. The company has since grown into a £42 million business, despite facing scepticism from investors who initially saw women's wellness as too niche.

Keep ReadingShow less